An extension trial of intrathecal therapy with monoclonal antibodies in progressive multiple sclerosis
- Registry ID
- EUCTR2012-000721-53
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Dept of Neurology, Umeå University Hospital, Umeå, Sweden
- Start date
- 2012-12-07
- Completion date
- 2018-06-07
- Last update
- 2026-08-16
Conditions
- Secondary progressive multiple sclerosis
Summary
To assess long-term stabilising effects of on neurological symptoms by regular IT administered monoclonal antibodies in MS.
Locations
View on source registry